Skip to main content

This job has expired

Evidence Based Manager (HEOR)

Employer
UCB S.A
Location
Slough, Berkshire (GB)
Salary
Competitive
Start date
7 Nov 2019
Closing date
7 Dec 2019

View more

Discipline
HEOR, Health Economics
Hours
Full Time
Contract Type
Permanent
Experience Level
Experienced (non-manager)

Job Details

Evidence Based Manager (HEOR)
UCB – Inspired by patients. Driven by science.
Help us transform patients’ lives.

About UCB

At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talent makes the most of who they are, unlocking innovation and setting new standards for patients.

Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?” And to find the answers, we connect globally with patients and their families living with the physical and social burdens of severe disease. These connections give us new perspectives, drive our innovation, and offer a hope for a new generation of therapies that will help to transform lives.

To strengthen our UK Market Access Group, we are looking to fill the position of: Evidence Based Manager.

About the Role:
You will be responsible for:

Gaining national and local reimbursement and access for aligned UCB products.

  • Developing and implementing affiliate appropriate network meta-analyses, mixed treatment comparisons, systematic reviews, meta-analyses and adjusted indirect comparisons.
  • Ensuring that PII/III trial programmes for New Medicines reflects UK clinical needs.
  • Identifying the need for Real World Evidence generation and subsequent development of proposals/protocols.

Leading, writing and coordinating the HTA content across selected UCB medicines.

  • Writing the clinical efficacy and safety sections of selected HTA submissions.
  • Day to day project management of selected HTA submissions.
  • Co-ordination of submission including Global inputs on strategy and content.

Gathering and developing external insights and evidence.

  • Increasing UCB profile in the field of Evidence based HTA and develop external partnerships with HTA and academic bodies.  
  • Representing UCB across aligned products, with HTA bodies on all aspects of medical and safety section of the HTA submission.
  • Co-ordinating company responses to Commissioning Outcomes Framework (COF), Quality Outcomes Framework (QOF), Quality Standards and Guideline reviews.

About You
You should have:

  • Degree in life sciences/EBM/Public Health/Epidemiology or equivalent. 
  • Experience in writing clinical or scientific dossiers.                   
  • Previous experience of working on HTA or Clinical Guidelines or similar projects.
  • Knowledge of UK and Ireland Healthcare and HTA system.
  • Excellent written and data analysis skills.
  • Good knowledge of clinical documentation.
  • Ability to manage network analyses, mixed treatment comparisons, systematic reviews and meta-analyse.
  • Experience with data collection and utilisation of Real world evidence for purposes of Access and uptake ideally.

UCB – The Facts

With more than 7500 employees in approximately 40 countries, we are a global biopharmaceutical company headquartered in Brussels, Belgium which invests more than 25% of revenue in cutting-edge scientific research to meet unmet patient needs. A few other reasons that make UCB an amazing place to work:

  • Promising pipeline that includes several novel molecules and no major patent expiration in the next decade;
  • About 25% of 2016 revenue reinvested into Research & Development
  • 2016 Key Financials: €4.2 billion global revenue Specialties: Neurology, Immunology

Company

A global biopharma company, focusing on neurology and immunology.

Our business is strong. Total revenue grew to €4.9 billion in 2019. We are more than 7,600 people in all four corners of the globe, inspired by patients and driven by science.

Our vision

UCB’s ambition is to transform the lives of people living with severe diseases. We focus on neurology and immunology disorders – putting patients at the center of our world. We are Inspired by Patients. Driven by Science.

UCB is continuously working to advance science and embrace new knowledge. We are leveraging scientific advances and skills in areas such as genetics, biomarkers and human biology. Patients inspire us to bring them value through cutting-edge science, innovative drugs, and practical solutions – so that they and their carers can get on with their lives.

Our strategy

We recognise that radical changes are taking place in the eco-system of care and that we need to evolve accordingly to deliver on our vision. The key element of our evolution is to focus on the delivery of increased patient value.

There is no such thing as an “average patient”. We want to use all the tools, channels and scientific advances at our disposal to develop a better understanding of the various expressions of a disease and embed the real needs of specific patient populations in our science and innovation process.

That is why we support patient groups who provide valuable services to patient communities and understand what matters to people living with severe diseases.

We believe in partnership. Our scientists collaborate with leading researchers from academia and industry to advance science and deliver the solutions patients need. Our open approach to innovation equips us to meet today’s biggest healthcare challenges.

Company info
Website
Telephone
+32 2 559 92 64
Location
Allée de la Recherche,
60
1070
Brussels
BE

Get job alerts

Create a job alert and receive personalised job recommendations straight to your inbox.

Create alert